Wyeth v. Levine
From Wikipedia, the free encyclopedia
Wyeth v. Levine
Argued November 3, 2008
Full case name: Wyeth, Petitioner v. Diana Levine
Docket no.: 06-1249
Questions presented
Do federal drug labeling requirements preempt different state drug labeling requirements that were enacted to ensure that the public knew certain drugs are safe?
Court membership
Chief Justice: John G. Roberts
Associate Justices: John Paul Stevens, Antonin Scalia, Anthony Kennedy, David Souter, Clarence Thomas, Ruth Bader Ginsburg, Stephen Breyer, Samuel Alito
Associate Justices: John Paul Stevens, Antonin Scalia, Anthony Kennedy, David Souter, Clarence Thomas, Ruth Bader Ginsburg, Stephen Breyer, Samuel Alito
Wyeth v. Levine, Docket 06-1249, is a case to be heard by the United States Supreme Court to decide whether plaintiffs have a right to sue a pharmaceutical company for injuries or death from a medication approved by federal regulators.
Former Solicitor General Seth P. Waxman, now a partner at WilmerHale L.L.P., will argue the case for the petitioner.
[edit] See also
Riegel v. Medtronic, Inc. (2008) Warner-Lambert Co. v. Kent (2008)
[edit] Further reading
Curfman, Gregory D.; Morrissey, Stephen; Drazen, Jeffrey M. (2008). "Why Doctors Should Worry about Preemption". New England Journal of Medicine 359 (1): 1–3. doi:. Greenhouse, Linda (2008-03-04). "Court Allows Suit Against Drug Maker", New York Times.
[edit] External links
This article related to the Supreme Court of the United States is a stub. You can help Wikipedia by expanding it.
